ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis

Cell Death and Disease

Volumn 6, Issue 6, 2015, Pages

  Yang, M ^a   Liu, J ^a   Piao, C ^a   Shao, J ^b   Du, J ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; MACROPHAGE DERIVED CHEMOKINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSFORMING GROWTH FACTOR BETA; ICAM1 PROTEIN, MOUSE;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL INFILTRATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; EFFEROCYTOSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MACROPHAGE; MEMBRANE BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; ANIMAL; C57BL MOUSE; COLON TUMOR; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER; LIVER TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PHAGOCYTOSIS; SECONDARY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COLONIC NEOPLASMS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIVER; LIVER NEOPLASMS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM METASTASIS; PHAGOCYTOSIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84989967720     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.144     Document Type: Article

References (62)

1. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141: 39-51.
2. Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012; 33: 119-126.
3. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12: 253-268.
4. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat Immunol 2010; 11: 889-896.
5. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229: 176-185.
6. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
7. Gordon S, Martinez FO. Alternative activation of macrophages: Mechanism and functions. Immunity 2010; 32: 593-604.
8. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol 2002; 196: 254-265.
9. Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 167: E211-e219.
10. Qing W, Fang WY, Ye L, Shen LY, Zhang XF, Fei XC et al. Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma. Thyroid 2012; 22: 905-910.
11. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Okumura H, Matsumoto M et al. Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res 2003; 23: 4079-4083.
12. Lee CH, Espinosa I, Vrijaldenhoven S, Subramanian S, Montgomery KD, Zhu S et al. Prognostic significance of macrophage infiltration in leiomyosarcomas. Clin Cancer Res 2008; 14: 1423-1430.
13. Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF et al. CSF-1 R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 2013; 19: 1264-1272.
14. Yang M, Liu J, Shao J, Qin Y, Ji Q, Zhang X et al. Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization. Mol Cancer 2014; 13: 43.
15. Yang M, Shao JH, Miao YJ, Cui W, Qi YF, Han JH et al. Tumor cell-activated CARD9 signaling contributes to metastasis-associated macrophage polarization. Cell Death Differ 2014; 21: 1290-1302.
16. De Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013; 23: 277-286.
17. Gregory CD, Pound JD. Cell death in the neighbourhood: Direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J Pathol 2011; 223: 177-194.
18. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: Clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2: 965-975.
19. Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 2007; 171: 2-8.
20. Kim S, Chung EY, Ma X. Immunological consequences of macrophage-mediated clearance of apoptotic cells. Cell Cycle 2005; 4: 231-234.
21. Vandivier RW, Henson PM, Douglas IS. Burying the dead: The impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006; 129: 1673-1682.
22. Filardy AA, Pires DR, Nunes MP, Takiya CM, Freire-de-Lima CG, Ribeiro-Gomes FL et al. Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high) regulatory phenotype in macrophages. J Immunol 2010; 185: 2044-2050.
23. Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res 2013; 113: 1004-1012.
24. Heo KS, Cushman HJ, Akaike M, Woo CH, Wang X, Qiu X et al. ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis. Circulation 2014; 130: 180-191.
25. Stanford JC, Young C, Hicks D, Owens P, Williams A, Vaught DB et al. Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution. J Clin Invest 2014; 124: 4737-4752.
26. Soki FN, Koh AJ, Jones JD, Kim YW, Dai J, Keller ET et al. Polarization of prostate cancerassociated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis. J Biol Chem 2014; 289: 24560-24572.
27. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988; 52: 925-933.
28. Hubbard AK, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 2000; 28: 1379-1386.
29. Zimmerman T, Blanco FJ. Inhibitors targeting the LFA-1/ICAM-1 cell-adhesion interaction: Design and mechanism of action. Curr Pharm Des 2008; 14: 2128-2139.
30. Hua S. Targeting sites of inflammation: Intercellular adhesion molecule-1 as a target for novel inflammatory therapies. Front Pharmacol 2013; 4: 127.
31. Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831-836.
32. Duperray A, Languino LR, Plescia J, McDowall A, Hogg N, Craig AG et al. Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem 1997; 272: 435-441.
33. Dustin ML, Bivona TG, Philips MR. Membranes as messengers in T cell adhesion signaling. Nat Immunol 2004; 5: 363-372.
34. Springer TA. The sensation and regulation of interactions with the extracellular environment: The cell biology of lymphocyte adhesion receptors. Annu Rev Cell Biol 1990; 6: 359-402.
35. Hamai A, Meslin F, Benlalam H, Jalil A, Mehrpour M, Faure F et al. ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway. Cancer Res 2008; 68: 9854-9864.
36. Maeda K, Kang SM, Sawada T, Nishiguchi Y, Yashiro M, Ogawa Y et al. Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol Rep 2002; 9: 511-514.
37. Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D et al. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One 2010; 5: Pii: E13091.
38. Hong Y, Downey T, Eu KW, Koh PK, Cheah PYA. 'Metastasis-prone' signature for earlystage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis 2010; 27: 83-90.
39. Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Gremy G et al. Deciphering cellular states of innate tumor drug responses. Genome Biol 2006; 7: R19.
40. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 2007; 8: R131.
41. Condeelis J, Pollard JW. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124: 263-266.
42. Rossi A, Lord J. Adiponectin inhibits neutrophil phagocytosis of Escherichia coli by inhibition of PKB and ERK 1/2 MAPK signalling and Mac-1 activation. PLoS One 2013; 8: E69108.
43. Lee HG, Minematsu H, Kim KO, Celil Aydemir AB, Shin MJ, Nizami SA et al. Actin and ERK1/2-CEBPbeta signaling mediates phagocytosis-induced innate immune response of osteoprogenitor cells. Biomaterials 2011; 32: 9197-9206.
44. Zizza P, Iurisci C, Bonazzi M, Cossart P, Leslie CC, Corda D et al. Phospholipase A2IValpha regulates phagocytosis independent of its enzymatic activity. J Biol Chem 2012; 287: 16849-16859.
45. Gregory CD, Devitt A. The macrophage and the apoptotic cell: An innate immune interaction viewed simplistically? Immunology 2004; 113: 1-14.
46. Devitt A, Marshall LJ. The innate immune system and the clearance of apoptotic cells. J Leukoc Biol 2011; 90: 447-457.
47. Hayes SH, Seigel GM. Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues. Int J Clin Exp Pathol 2009; 2: 553-560.
48. Anastassiou G, Schilling H, Stang A, Djakovic S, Heiligenhaus A, Bornfeld N. Expression of the cell adhesion molecules ICAM-1, VCAM-1 and NCAM in uveal melanoma: A clinicopathological study. Oncology 2000; 58: 83-88.
49. Schmits R, Kundig TM, Baker DM, Shumaker G, Simard JJ, Duncan G et al. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J Exp Med 1996; 183: 1415-1426.
50. Korns D, Frasch SC, Fernandez-Boyanapalli R, Henson PM, Bratton DL. Modulation of macrophage efferocytosis in inflammation. Front Immunol 2011; 2: 57.
51. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002; 417: 182-187.
52. Friggeri A, Yang Y, Banerjee S, Park YJ, Liu G, Abraham E. HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin. Am J Physiol Cell Physiol 2010; 299: C1267-C1276.
53. Banerjee S, de Freitas A, Friggeri A, Zmijewski JW, Liu G, Abraham E. Intracellular HMGB1 negatively regulates efferocytosis. J Immunol 2011; 187: 4686-4694.
54. Thorp E, Subramanian M, Tabas I. The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. Eur J Immunol 2011; 41: 2515-2518.
55. Choi JY, Park HJ, Lee YJ, Byun J, Youn YS, Choi JH et al. Upregulation of Mer receptor tyrosine kinase signaling attenuated lipopolysaccharide-induced lung inflammation. J Pharmacol Exp Ther 2013; 344: 447-458.
56. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002; 109: 41-50.
57. Parsa KV, Butchar JP, Rajaram MV, Cremer TJ, Tridandapani S. The tyrosine kinase Syk promotes phagocytosis of Francisella through the activation of Erk. Mol Immunol 2008; 45: 3012-3021.
58. Beemiller P, Zhang Y, Mohan S, Levinsohn E, Gaeta I, Hoppe AD et al. A Cdc42 activation cycle coordinated by PI 3-kinase during Fc receptor-mediated phagocytosis. Mol Biol Cell 2010; 21: 470-480.
59. Zheng J, Yang M, Shao J, Miao Y, Han J, Du J. Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis. Mol Cancer 2013; 12: 141.
60. Yang M, Zheng J, Miao Y, Wang Y, Cui W, Guo J et al. Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler Thromb Vasc Biol 2012; 32: 1675-1686.
61. Kojima Y, Downing K, Kundu R, Miller C, Dewey F, Lancero H et al. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest 2014; 124: 1083-1097.
62. Bae HB, Tadie JM, Jiang S, Park DW, Bell CP, Thompson LC et al. Vitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophages. J Immunol 2013; 190: 2273-2281.